首页 > 最新文献

Infectious Diseases: News, Opinions, Training最新文献

英文 中文
Revaccination against COVID-19: the current state of the problem (lecture preparation material) 重新接种COVID-19疫苗:问题的现状(讲座准备材料)
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-3-131-136
M.P. Kostinov, N.P. Andreeva, S.R. Raicic, A.M. Kostinova
{"title":"Revaccination against COVID-19: the current state of the problem (lecture preparation material)","authors":"M.P. Kostinov, N.P. Andreeva, S.R. Raicic, A.M. Kostinova","doi":"10.33029/2305-3496-2023-12-3-131-136","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-3-131-136","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136202649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possibilities for early prediction of COVID-19 outcomes in hospitalized patients 早期预测住院患者COVID-19结局的可能性
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-3-33-38
N.A. Ilina, T.M. Klimova, S.S. Sleptsov, S.S. Sleptsovа
{"title":"Possibilities for early prediction of COVID-19 outcomes in hospitalized patients","authors":"N.A. Ilina, T.M. Klimova, S.S. Sleptsov, S.S. Sleptsovа","doi":"10.33029/2305-3496-2023-12-3-33-38","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-3-33-38","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136202845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Online survey results among social network users in terms of the COVID-19 problem 社交网络用户关于新冠肺炎问题的在线调查结果
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-1-26-33
A. R. Tyapayeva, E. Naumova, O. Semenova
Aim. An online survey among social network users was conducted to assess the frequency of COVID-19 cases, the spectrum of medications used for treatment, and the subjective assessment of clinical manifestations of the disease. Material and methods. An anonymous online survey was conducted among users of various social networks using a questionnaire created on the SurveyMonkey survey and research platform. During the first month of December 2021, the survey included 23 questions regarding the clinical and demographic characteristics of respondents, the number of COVID-19 cases, clinical manifestations, and severity, as well as the need for medical help and medication. Results. 752 respondents took part in the online survey, more than 70% of them are under 50 years old. Among the respondents 59.73% had a new coronavirus infection (COVID-19). More than 40% of the participants had COVID-19 in the period from September 2020 to April 2021 (2nd wave in Russia). In 79.2% of people, the presence of a new coronavirus infection was confirmed by one of the diagnostic methods: polymerase chain reaction (PCR test), radiography, the presence of antibodies to Ig G/M, and took into account the presence of contact with infected SARS-CoV-2. 411 participants observed any clinical manifestations of the disease. Most often respondents who had COVID-19 indicated weakness, cough, dyspnea, disappearance or decrease in the acuity of smell and taste. The volume of lung tissue damage in 36.5% of cases was less than 25%. The disappearance of any clinical manifestations of the disease immediately after recovery was noted by 32.0% of respondents. Most of the patients (59.2%) sought medical help at the polyclinic, 38.9% had to self-medicate. 71.9% respondents indicated they had been vaccinated against COVID-19, but without specifying the timing and completeness of the course. Side effects after immunization (fever, weakness, soreness, and redness at the injection site) were subjectively assessed by 41.9% of respondents. Conclusion. Among the surveyed respondents, 62.7% of the disease symptoms were mild. The highest number of cases occurred in the 2nd and 4th waves of COVID-19 morbidity in Russia. Most often respondents indicated symptoms of acute respiratory infection. The complete disappearance of clinical manifestations of the disease immediately after recovery was noted by 32.0 % of respondents, and the persistence of symptoms for up to a year - 7.5. More than 70% of the participants in the online survey reported vaccination against COVID-19, but the questionnaire did not include questions about the timing of vaccinations (before or after COVID-19) and the completeness of the course.Copyright © Eco-Vector, 2023. All rights reserved.
的目标。在社交网络用户中开展了一项在线调查,以评估COVID-19病例的频率、用于治疗的药物范围以及对疾病临床表现的主观评估。材料和方法。通过在SurveyMonkey调查和研究平台上创建的问卷,在各种社交网络的用户中进行了一项匿名在线调查。在2021年12月的第一个月,调查包括23个问题,涉及受访者的临床和人口特征、COVID-19病例数、临床表现和严重程度,以及对医疗帮助和药物的需求。结果:752名受访者参与了在线调查,其中超过70%的受访者年龄在50岁以下。受访者中有59.73%的人感染了新型冠状病毒(COVID-19)。超过40%的参与者在2020年9月至2021年4月期间感染了COVID-19(俄罗斯的第二波)。79.2%的人通过以下诊断方法之一确诊为新型冠状病毒感染:聚合酶链反应(PCR试验)、x线摄影、igg /M抗体的存在,并考虑到是否与感染的SARS-CoV-2接触。411名参与者观察到疾病的任何临床表现。大多数感染COVID-19的受访者都表现出虚弱、咳嗽、呼吸困难、嗅觉和味觉灵敏度消失或下降。36.5%的病例肺组织损伤体积小于25%。32.0%的受访者在康复后立即发现疾病的任何临床表现消失。大多数患者(59.2%)到综合诊所寻求医疗帮助,38.9%的患者不得不自行用药。71.9%的受访者表示,他们已经接种了COVID-19疫苗,但没有说明接种的时间和完整程度。41.9%的应答者主观评价了免疫后的副作用(发热、虚弱、疼痛和注射部位发红)。结论。在被调查者中,62.7%的人的疾病症状较轻。在俄罗斯,病例数最多的是第二波和第四波COVID-19发病率。大多数答复者表示有急性呼吸道感染的症状。32.0%的应答者在康复后立即注意到疾病的临床表现完全消失,并且症状持续长达一年- 7.5%。超过70%的在线调查参与者报告了针对COVID-19的疫苗接种,但问卷不包括有关疫苗接种时间(在COVID-19之前或之后)和课程完整性的问题。版权所有©Eco-Vector, 2023。版权所有。
{"title":"Online survey results among social network users in terms of the COVID-19 problem","authors":"A. R. Tyapayeva, E. Naumova, O. Semenova","doi":"10.33029/2305-3496-2023-12-1-26-33","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-1-26-33","url":null,"abstract":"Aim. An online survey among social network users was conducted to assess the frequency of COVID-19 cases, the spectrum of medications used for treatment, and the subjective assessment of clinical manifestations of the disease. Material and methods. An anonymous online survey was conducted among users of various social networks using a questionnaire created on the SurveyMonkey survey and research platform. During the first month of December 2021, the survey included 23 questions regarding the clinical and demographic characteristics of respondents, the number of COVID-19 cases, clinical manifestations, and severity, as well as the need for medical help and medication. Results. 752 respondents took part in the online survey, more than 70% of them are under 50 years old. Among the respondents 59.73% had a new coronavirus infection (COVID-19). More than 40% of the participants had COVID-19 in the period from September 2020 to April 2021 (2nd wave in Russia). In 79.2% of people, the presence of a new coronavirus infection was confirmed by one of the diagnostic methods: polymerase chain reaction (PCR test), radiography, the presence of antibodies to Ig G/M, and took into account the presence of contact with infected SARS-CoV-2. 411 participants observed any clinical manifestations of the disease. Most often respondents who had COVID-19 indicated weakness, cough, dyspnea, disappearance or decrease in the acuity of smell and taste. The volume of lung tissue damage in 36.5% of cases was less than 25%. The disappearance of any clinical manifestations of the disease immediately after recovery was noted by 32.0% of respondents. Most of the patients (59.2%) sought medical help at the polyclinic, 38.9% had to self-medicate. 71.9% respondents indicated they had been vaccinated against COVID-19, but without specifying the timing and completeness of the course. Side effects after immunization (fever, weakness, soreness, and redness at the injection site) were subjectively assessed by 41.9% of respondents. Conclusion. Among the surveyed respondents, 62.7% of the disease symptoms were mild. The highest number of cases occurred in the 2nd and 4th waves of COVID-19 morbidity in Russia. Most often respondents indicated symptoms of acute respiratory infection. The complete disappearance of clinical manifestations of the disease immediately after recovery was noted by 32.0 % of respondents, and the persistence of symptoms for up to a year - 7.5. More than 70% of the participants in the online survey reported vaccination against COVID-19, but the questionnaire did not include questions about the timing of vaccinations (before or after COVID-19) and the completeness of the course.Copyright © Eco-Vector, 2023. All rights reserved.","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69484620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Latent hepatitis B diagnostic approach improvement in blood donors 献血者潜伏性乙型肝炎诊断方法的改进
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-1-54-61
V. K. Fazylov, Zh. G. Eremeeva, R. Turaev
{"title":"Latent hepatitis B diagnostic approach improvement in blood donors","authors":"V. K. Fazylov, Zh. G. Eremeeva, R. Turaev","doi":"10.33029/2305-3496-2023-12-1-54-61","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-1-54-61","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69484701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The reveal of novel members of Orthopoxvirus genus 正痘病毒属新成员的发现
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-2-8-13
G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. Borisevich
{"title":"The reveal of novel members of Orthopoxvirus genus","authors":"G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. Borisevich","doi":"10.33029/2305-3496-2023-12-2-8-13","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-2-8-13","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69484445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the need and peculiarities of vaccination against COVID-19 in patients with neurological disorders 神经系统疾病患者COVID-19疫苗接种的必要性和特点
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-2-93-99
S. Raicic, M. Kostinov, E. G. Simonova, G. G. Kharseeva
{"title":"On the need and peculiarities of vaccination against COVID-19 in patients with neurological disorders","authors":"S. Raicic, M. Kostinov, E. G. Simonova, G. G. Kharseeva","doi":"10.33029/2305-3496-2023-12-2-93-99","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-2-93-99","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69484459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The frequency and sensitivity to antimicrobial drugs of Staphylococcus aureus and Pseudomonas aeruginosa isolates from the lower respiratory tract in children with cystic fibrosis 囊性纤维化儿童下呼吸道金黄色葡萄球菌和铜绿假单胞菌分离株抗菌药物的频率和敏感性
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-1-62-68
T. V. Tronza, A. Voronkova, N.Ya. Fedotova, I. R. Fatkhullina, E. Tivanova, A. Ploskireva, A. Gorelov, E. Kondratyeva, V. Akimkin
{"title":"The frequency and sensitivity to antimicrobial drugs of Staphylococcus aureus and Pseudomonas aeruginosa isolates from the lower respiratory tract in children with cystic fibrosis","authors":"T. V. Tronza, A. Voronkova, N.Ya. Fedotova, I. R. Fatkhullina, E. Tivanova, A. Ploskireva, A. Gorelov, E. Kondratyeva, V. Akimkin","doi":"10.33029/2305-3496-2023-12-1-62-68","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-1-62-68","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69484707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features of management of patients with COVID-19 and secondary immunodeficiency in real clinical practice 现实临床中COVID-19合并继发性免疫缺陷患者的处理特点
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-3-61-70
V.P. Sereda, K.A. Tikhonova, I.S. Moroz, A.M. Tuktarov
{"title":"Features of management of patients with COVID-19 and secondary immunodeficiency in real clinical practice","authors":"V.P. Sereda, K.A. Tikhonova, I.S. Moroz, A.M. Tuktarov","doi":"10.33029/2305-3496-2023-12-3-61-70","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-3-61-70","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"97 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136202255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of bedaquiline on the course of HIV-infection combined with tuberculosis 贝达喹啉对hiv感染合并结核病程的影响
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-3-26-32
G.S. Balasaniants, N.V. Golub, Yu.N. Shitov
{"title":"Influence of bedaquiline on the course of HIV-infection combined with tuberculosis","authors":"G.S. Balasaniants, N.V. Golub, Yu.N. Shitov","doi":"10.33029/2305-3496-2023-12-3-26-32","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-3-26-32","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136202425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis, treatment and follow-up of patients with alveolar echinococcosis (lecture preparation material) 肺泡包虫病的诊断、治疗及随访(讲座准备材料)
Q4 Social Sciences Pub Date : 2023-01-01 DOI: 10.33029/2305-3496-2023-12-3-137-145
O.P. Zelya, V.D. Zavoikin, N.I. Tumolskaya
{"title":"Diagnosis, treatment and follow-up of patients with alveolar echinococcosis (lecture preparation material)","authors":"O.P. Zelya, V.D. Zavoikin, N.I. Tumolskaya","doi":"10.33029/2305-3496-2023-12-3-137-145","DOIUrl":"https://doi.org/10.33029/2305-3496-2023-12-3-137-145","url":null,"abstract":"","PeriodicalId":36113,"journal":{"name":"Infectious Diseases: News, Opinions, Training","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136202453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infectious Diseases: News, Opinions, Training
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1